Losing weight for a better health: Role for the gut microbiota

Slides:



Advertisements
Similar presentations
UAB Metabolomics Symposium December 12, 2012 Christopher B. Newgard, Ph.D. Sarah W. Stedman Nutrition and Metabolism Center Department of Pharmacology.
Advertisements

Walter Lab: Gut microbiome and its interactions with metabolic disease
1 Future Areas of Research Intervention Approaches Causes and Mechanisms of Overweight and Obesity Abdominal Fat, Body Weight and Disease Risk Assessment.
Copyright © 2009, by Mosby, Inc. an affiliate of Elsevier, Inc. All rights reserved.1 Chapter 15 Weight Management.
Weight Management 1. America is getting heavier 66% of adults ages 20 to 74 years are overweight – Of this number, 32% meet criteria for obesity Center.
Carbohydrate and fat utilization during rest and physical activity Katarina Melzer European e-Journal of Clinical Nutrition and Metabolism Volume 6, Issue.
What’s All the Fuss About the Microbiome?
Role of thyroid hormone homeostasis in obesity-prone and obesity-resistant mice fed a high-fat diet  Shu-Fang Xia, Xiao-Mei Duan, Li-Yue Hao, Li-Ting.
NATIONAL NUTRITIONAL PHENOTYPE DATABASE
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Obesity and the Microbiota
Clinical Nutrition Experimental
Elaine Holmes, Jia V. Li, Julian R. Marchesi, Jeremy K. Nicholson 
برهم کنش مواد مغذی و ژن در دفاع سلولی بدن
Volume 25, Issue 3, Pages (March 2017)
Nicholas A. Bokulich, Martin J. Blaser  Cell Metabolism 
Gut bacterial microbiota and obesity
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
This Gut Ain’t Big Enough for Both of Us. Or Is It
The microbiome in allergic disease: Current understanding and future opportunities— 2017 PRACTALL document of the American Academy of Allergy, Asthma &
Alcohol and toxicity Journal of Hepatology
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Microbial Modulation of Insulin Sensitivity
Vitamin D and breast cancer: Indian perspective
Antibiotic Exposure Promotes Fat Gain
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Microbiome at the Frontier of Personalized Medicine
Fibrosis and Adipose Tissue Dysfunction
Lotta Nylund, Katri Kaukinen, Katri Lindfors 
Microbiome at the Frontier of Personalized Medicine
Mahmoud Mustafa Ali Abulmeaty  Clinical Nutrition Experimental 
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Metabolic Phenotyping in Health and Disease
Differences in dietary choices in patients who developed postprandial hyperinsulinemic hypoglycemia (dumping syndrome) after Roux-en-Y gastric bypass.
Laure B. Bindels, Jean-Paul Thissen  Clinical Nutrition Experimental 
Nitzan Koppel, Emily P. Balskus  Cell Chemical Biology 
Practical Challenges in Obesity: Is It Possible to Maintain Weight Loss?
Volume 25, Issue 3, Pages (March 2017)
Perinatal nutrition: How to take care of the gut microbiota?
Juleen R. Zierath, Harriet Wallberg-Henriksson  Cell Metabolism 
Metabolomics and Metabolic Diseases: Where Do We Stand?
The National Biome Initiative: An allergy perspective
The Human Microbiome and Obesity: Moving beyond Associations
Chad M. Trent, Martin J. Blaser  Cell Metabolism 
It’s in the Milk: Feeding the Microbiome to Promote Infant Growth
Pathways in Microbe-Induced Obesity
Clinical Microbiology and Infection
Branching Out for Detection of Type 2 Diabetes
Membrane fatty acid composition of different target populations: Importance of baseline on supplementation  Veronica Silva, Pierre Singer  Clinical Nutrition.
Treating Obesity as a Disease: What Are the Underlying Causes?
High Glycemic Index Metabolic Damage – a Pivotal Role of GIP and GLP-1
Bridging immunity and lipid metabolism by gut microbiota
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Innate sensors of pathogen and stress: Linking inflammation to obesity
Obesity and the Microbiota
Microbiome contribution and metabolite intervention in post-dieting weight-regain MSc. Lenka Dohnalová, July 2017, Munich.
Adil Mardinoglu, Jan Boren, Ulf Smith  Cell Metabolism 
Clinical Nutrition Experimental
Fighting Undernutrition: Don’t Forget the Bugs
Is the association between vitamin D, adiponectin, and insulin resistance present in normal weight or obese? A pilot study  Marina Carvalho-Rassbach,
Microbiome as a therapeutic target in alcohol-related liver disease
Volume 24, Issue 12, Pages (September 2018)
Kian Fan Chung, MD, DSc, FRCP 
Gut Microbiome Studies
Impact of vitamin D on infectious disease-tuberculosis-a review
Transforming medicine with the microbiome
Najate Achamrah, Pierre Déchelotte, Moïse Coëffier 
Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? 
(A) Metabolic niches in the gut microbiome.
Intestinal microbiota and Anorexia Nervosa
Presentation transcript:

Losing weight for a better health: Role for the gut microbiota Maria Carlota Dao, Amandine Everard, Karine Clément, Patrice D. Cani  Clinical Nutrition Experimental  Volume 6, Pages 39-58 (April 2016) DOI: 10.1016/j.yclnex.2015.12.001 Copyright © 2015 The Authors Terms and Conditions

Fig. 1 Comparing responses to weight loss interventions through extensive phenotyping and data integration. There are phenotypic and behavioral traits that differentiate responders vs. non-responders to weight loss interventions. These differences can be compared 1) at baseline, between responders (status Y) and non-responders (status X) for prediction (yellow profile vs. orange profile), and 2) before vs. after the intervention (yellow profile vs. blue profile) to study mechanisms that may be involved in a good response to the intervention. Environment may refer to diet, exercise, behavior, and other environmental exposures. Omics may refer to genomics, epigenomics, transcriptomics, proteomics and metabolomics in different tissues. Clinical Nutrition Experimental 2016 6, 39-58DOI: (10.1016/j.yclnex.2015.12.001) Copyright © 2015 The Authors Terms and Conditions

Fig. 2 Dietary intervention such as prebiotic supplementation as well as gastric surgery impact gut microbiota and host metabolism and thereby represent interesting approaches for the treatment of obesity and metabolic disorders. Obesity is associated with alterations in metabolism and energy homeostasis. Gastric bypass surgery is associated with changes in gut microbiota composition and metabolic functions and represents one of the more effective approaches to treat obesity and metabolic disorders. Dietary interventions targeting the gut microbiota, such as prebiotics, induce changes in gut microbiota composition that are associated with modification of the secretion of gut enteroendocrine hormones as well as with a reduction in metabolic inflammation, and glucose, lipid and energy homeostasis dysfunctions. Clinical Nutrition Experimental 2016 6, 39-58DOI: (10.1016/j.yclnex.2015.12.001) Copyright © 2015 The Authors Terms and Conditions

Fig. 3 Modelisation of the gut ecosystem as a first step for personalized nutrition. Individuals with low and high gut microbial richness differ in certain clinical parameters, dietary intake and metabolite profile. The CASINO toolbox predicts, at the individual level, differences in metabolite production by gut bacteria and proposes changes in dietary intake for individuals with low gene richness to improve their gut microbiome metabolism. BCAAs, branched chain amino acids. Clinical Nutrition Experimental 2016 6, 39-58DOI: (10.1016/j.yclnex.2015.12.001) Copyright © 2015 The Authors Terms and Conditions